Sunscreen mousse may be dangerous — here's what you need to know
But the US Food and Drug Administration just issued warnings to several popular sunscreen brands, suggesting that there is one type of sunscreen that is better left on the shelf. These brands all sell trendy mousse sunscreens (also called whipped sunscreen), and the FDA says this specific type of formulation may not be safe. Below, everything you need to know about this warning.
Why is the FDA issuing warnings about mousse sunscreen?
Whipped sunscreens from brands like Supergoop! and Vacation Inc. have been one of the trendier beauty products of the summer. But the FDA is letting consumers know that they should proceed with caution. On August 12, they posted a message on X that said, 'Beware of sunscreen products in mousse form because they might not be effective. The FDA issued five warning letters to companies marketing sunscreen products in mousse form.'
The FDA explained that regulations allow brands to market sunscreens as creams, lotions, sticks, sprays and a few other formulations — but they do not allow for mousse or whipped formulations. They also said that certain companies have created bottles that look like cans of whipped cream, which can put consumers at risk if ingested.
The brands that received warning letters are Supergoop!, Vacation Inc., Kalani Sunwear, Fallian Cosmeceuticals (TiZo brand) and K & Care Organics. These letters don't necessarily mean the mousse sunscreens produced by these brands are unsafe. The FDA just requires that any new form is required to have sufficient data proving they are safe and effective — and those things haven't been submitted.
The brands have 15 working days to respond. If they fail to comply, it is possible that the products could be pulled from the market.
The coming weeks will be very telling when it comes to mousse sunscreens and whether or not these companies address the concerns raised by the FDA. Until then, it may be a smarter move to stick to formulations not under attack by the FDA. Below, a few sunscreen options that have been recommended to us previously by experts or NBC Select staffers.
A favorite amongst NBC Select staffers, this sunscreen has an SPF 46 and is specifically made for the face. The oil-free formula utilizes zinc oxide as its main ingredient to physically block UVA and UVB rays. The formula is lightweight and good for those with sensitive skin, according to the brand.
Just because the mousse sunscreen from Supergoop was issued a warning, it doesn't mean all of the brand's products are off limits. This gel formula is another favorite of staffers. 'It has a smooth, almost silky feel to it that my skin absorbs quickly, giving the same finish as some of my high-end makeup primers,' says NBC Select associate reporter Ashley Morris.
The go-to sunscreen in my house, I love that I can quickly spray my kids down with SPF as we head out the door. It also absorbs quickly and has a pleasant coconut scent. Along with ingredients that protect your skin, this formula contains vitamin E to keep skin moisturized, according to the brand.
Why trust NBC Select?
Bethany Heitman is a contributor at NBC Select and a journalist who regularly covers topics like beauty, home and lifestyle and debunks popular skin care trends and online fads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
15 minutes ago
- New York Post
You can get a flu vaccine nasal spray shipped directly to your door this fall
Get a whiff of this. For the first time, Americans can now skip the doctor's office and pharmacy line for their annual flu vaccine — and they can avoid needles, too. AstraZeneca's FluMist Home program officially launches today, sending nasal flu vaccines straight to people's homes. 4 The flu can cause mild to severe illness and, in some cases, lead to death. – Advertisement FluMist is a flu vaccine that's sprayed up your nose. It's been FDA-approved since 2003, and studies show it works about as well as the traditional flu shot at preventing infections and reducing the risk of serious illness. Since hitting the market more than 20 years ago, the nasal spray had only available through healthcare providers. But this season, that's changing with FluMist Home. 'This will be the first time someone will be able to give themselves a flu vaccine right in their own home,' Dr. Ravi Jhaveri, a pediatric infectious disease specialist, told The Post. 'While that may seem intimidating, this is an incredible milestone to make vaccines more accessible.' How does FluMist Home work? Advertisement The program is available in 34 states this year, with plans to expand. If it isn't offered in your state yet — like New York — you can still get the spray at your doctor's office or pharmacy. Starting today, people in eligible states can visit to complete a medical screening questionnaire, get approved and choose a delivery date. The spray will arrive in an insulated package with cooling packs to ensure it's kept at the right temperature. Liz Bodin, vice president of US respiratory and immunology, vaccines and immune therapies at AstraZeneca, told The Post that it should be used immediately after it arrives or kept in the fridge for up to two months. Advertisement 4 FluMist works by stimulating the immune system in the nose and throat, where influenza viruses typically enter the body. AstraZeneca Is it really safe to administer your own flu vaccine? To earn FDA approval, AstraZeneca conducted a study testing whether adults could successfully administer a full dose of the nasal spray — either to themselves or a child — with the provided instructions. The result? A 100% success rate. 'I'm very confident that eligible patients can administer FluMist safely and effectively at home,' Bodin said. Each shipment includes instructions with 'how-to' guides, videos, a toll-free pharmacist call center and a pharmacist chat feature. Advertisement 4 Doctors say FluMist provides a good option for needle-shy kids and adults. MediaNews Group via Getty Images Who should get a nasal flu vaccine at home? FluMist is approved for self-administration by adults ages 18 to 49, or by parents and caregivers for children between 2 and 17 years old. 'Being able to administer the vaccine in the comfort of one's own home — and to your own children — makes protection more accessible, convenient, and better aligned with the realities and current preferences of people's lives,' said Jhaveri, who also serves as a professor of pediatrics at Northwestern University. 'If your little one has a fear of needles, or your doctor's office has no appointments, or you are coordinating a complicated matrix of work, school and after-school schedules, this might be an option for you this season,' he added. 4 The FluMist Home program aims to make vaccination easier for Americans with hectic schedules who might otherwise skip the doctor's appointment. Rido – How much does it cost? Since it's part of the CDC's recommended vaccines list, most insurance plans fully cover it. There's also an $8.99 shipping fee. Prices vary for those without insurance or whose plans don't cover it, but GoodRx lists coupons can bring the cost of the nasal spray down to around $30. Advertisement Why bother with a flu shot? The 2024–2025 flu season was the worst in 15 years, with preliminary CDC data reporting at least 47 million cases, 610,000 hospitalizations and 27,000 deaths nationwide — including 216 children. At the same time, vaccinations lagged across the board. Among Americans under 18, less than half got vaccinated, down from a pre-pandemic rate of 62.4% in 2019-20. 'I strongly encourage flu vaccination — whether it's your first time or not — because it remains one of the most effective ways to prevent flu,' Jhaveri, who is also division head of infectious diseases at Chicago's Lurie Children's Hospital, said. Advertisement 'Children are especially susceptible to serious complications from the flu, such as pneumonia or hospitalization, and 150-200 children die each season — many of whom are otherwise healthy. 'My recommendation is to get your flu vaccine by the end of October, before the virus starts to circulate. It's a vital step toward protecting yourself, your family and the wellbeing of those around you.'
WIRED
16 minutes ago
- WIRED
Now You Can Get Your Flu Vaccine at Home
Aug 15, 2025 8:00 AM The nasal spray vaccine FluMist can now be ordered online and shipped to your door. Photograph:Instead of going to the pharmacy to get the annual flu vaccine, many people in the US will now be able to get it shipped to their door to take at home themselves. Starting today, AstraZeneca's FluMist is available through an online pharmacy in 34 states. FluMist is not a new vaccine. It was originally approved by the Food and Drug Administration in 2003 and previously could only be administered by a health care professional. But last September, the FDA said the vaccine could be self-administered. It's AstraZeneca's first foray into direct-to-consumer medicine—a trend being spearheaded by Novo Nordisk and Eli Lilly to sell their popular GLP-1 drugs for diabetes and weight management to patients. 'We recognized that people's daily lives are busier than ever, and we knew we needed to meet people where they are facing the realities of real life,' said Tonya Villafana, vice president of medical and scientific affairs at AstraZeneca, at a press conference on Thursday. 'FluMist Home is designed to remove traditional obstacles to vaccination, things like scheduling clinic visits, waiting in line, and the fear of needles.' AstraZeneca is hoping that an at-home offering will help boost flu vaccination rates. Only about 47 percent of adults get vaccinated against flu, according to the Centers for Disease Control and Prevention. Among children, flu vaccination rates are dropping along with those of other routine childhood vaccines. As of April 26 this year, 49.2 percent of children received a flu vaccination—lower than 53.4 percent at the same time the previous season, per the CDC. 'Getting vaccinated each year is the best way to prevent influenza, which causes illness in a substantial proportion of the US population every year and may result in serious complications, including hospitalization and death,' said Peter Marks, former director of the FDA's Center for Biologics Evaluation and Research, in a statement last year on FluMist's approval for self-administration. The CDC classified the 2024-2025 flu season as high severity across all age groups in the US, resulting in at least 610,000 hospitalizations and 27,000 deaths. It was the most severe flu season since the 2009 H1N1 swine flu pandemic. AstraZeneca's September 2024 approval was based on a study with vaccine recipients and caregivers to evaluate whether the instructions for use were appropriately designed so that they could safely and effectively use the vaccine. The vaccine contains a weakened form of the live influenza virus and protects against four types of flu strains. It is approved for ages 2 through 49. For those under 18, it must be administered by a caregiver. To order, customers will need to complete a medical screening questionnaire. A licensed health care provider will review each submission to determine eligibility. Once eligibility is confirmed and insurance is verified, the vaccine will be prescribed and shipped directly to the purchaser's home on a date they select. FluMist is covered by most insurance plans, but consumers will need to pay an $8.99 delivery fee. AstraZeneca says FluMist is not yet available in all states due to local pharmacy laws, but the company aims to be able to provide the at-home spray to all the contiguous states in the future. The vaccine will continue to be available in doctors' offices and pharmacies for administration by health care professionals across the country.
CNN
16 minutes ago
- CNN
It's now possible to give yourself a flu vaccine at home
For the first time, many people in the United States who want to protect themselves against the flu this respiratory virus season can order a vaccine to give themselves at home. AstraZenca's FluMist, the only nasal spray flu vaccine in the US that has been approved by the US Food and Drug Administration, is now available for home delivery in 34 states under the brand name FluMist Home. It can be self-administered by adults under 50 and to children as young as 2 with the help of a parent or caregiver. The online ordering platform includes a brief medical screening questionnaire to be reviewed by a licensed health-care provider before prescribing the vaccine. It is covered by most commercial insurance, with an $8.99 fee for shipping and handling. FluMist has been on the market for more than two decades, receiving initial FDA approval in 2003. In September 2024, the FDA gave the green light for the nasal spray vaccine to be self-administered but it wasn't ready to reach the public in time for last respiratory virus season. Experts say this novel option for self-administration could be a useful tool to help improve vaccination rates at a critical time. Last flu season was unusually intense and severe. Preliminary estimates from the US Centers for Disease Control and Prevention suggest that there were up to 82 million illnesses, 1.3 million hospitalizations and 130,000 deaths from flu between October 2024 and May 2025 – but less than half of kids and adults in the US had gotten their annual flu vaccine. The general public is becoming 'increasingly comfortable' with home administration of drugs and biologics such as Covid-19 tests and GLP-1 injections, said Dr. Peter Hotez, a pediatrician who co-directs the Center for Vaccine Development at Texas Children's Hospital. 'We learned during Covid how home diagnostic testing became widely accepted and that turned out to be a great public health intervention,' Hotez said. 'Given the low uptake of seasonal flu vaccine in America, I think it is worth exploring some novel approaches.' With the rise of vaccine hesitancy and other challenges, it's key to remove as many barriers as possible, said Elizabeth Bodin, vice president of AstraZeneca's US respiratory and immunology vaccines and immune therapies team. 'There can be many reasons that patients maybe don't get vaccinated, but one of them can be the practical elements of booking appointments, convenience, being able to get in to see the doctor,' she said. 'The ability to go online and with a couple of clicks to be able to order FluMist, have it reviewed by a health care provider to ensure it's appropriate for you and your family and have it delivered to your doorstep, that can remove one of the barriers that may stand in the way of people getting vaccinated.' The data AstraZeneca presented to the FDA for approval of FluMist Home included a 'usability study' showing people can use it properly without a health-care provider present. The results showed that 100% of intended users administered a full dose, according to the drug company. A focus on patient-centered care creates pathways for people to take a leading role in their own health care, Bodin said. 'The population that I see benefiting from FluMist Home the most are individuals who are busy convenience-seekers or busy families,' she said. 'Maybe they're getting ready for back-to-school season, and it's one less item on their to-do list to book a clinic visit or a pharmacy visit. Knowing that they can bring FluMist Home right into their home and vaccinate on their schedule – the time they want, no waiting in line – makes it very manageable for them to ensure that they can protect their family for the upcoming flu season.' The vaccine that people can now self-administer at home will have the same vial, same vaccine formulation and same effectiveness as the FluMist used by health-care providers, AstraZeneca said. The vaccine is mailed in temperature-controlled packaging with a tag that patients scan to ensure the vaccine stayed at an appropriate temperature throughout the shipping process. The vial includes two pre-measured doses – one to squirt into each nostril, separated by a clip – and there are a variety of materials to support those who have questions. FluMist is the only needle-free option available for flu vaccination in the US. It uses a live, weakened version of the influenza virus to provide protection, but injectable flu vaccines use different technology: either killed viruses or proteins to train the immune system to fight off the virus. AstraZeneca says FluMist has been shown to be as effective as other flu vaccines. According to the FDA, the most commonly reported side effects of FluMist are runny nose and congestion, as well as a fever for young children and a sore throat in adults. The FDA issued recommendations for the the composition of the 2025-2026 flu vaccines in March, and Bodin says FluMist Home is 'ready to target' the virus likely to impact Americans most in the upcoming season.
